FOLH1 and neoplasm: However, TTV was comparable between STS and LTS patients, allowing the hypothesis that even patients with an extensive tumor load in terms of TTV might profit from RLT with 225Ac-PSMA-I&T and should not be excluded from RLT in the first place.